S. Seeber

Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP.

Gerry McLachlan, Ling‐Pei Ho, Hazel Davidson‐Smith et al. · PubMed · 1996 · 70 citations

Medicine, Molecular Biology, Molecular Genetics +10

Phase I/II study of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor in combination with FOLFIRI as first-line treatment for patients with metastatic colorectal cancer (CRC)

Tanja Trarbach, N. Schleucher, Mitra Tewes et al. · Journal of Clinical Oncology · 2005 · 53 citations

Medicine, Oncology, Pharmacology +17

Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial

O. Kloke, U. Klaassen, C. Oberhoff et al. · Breast Cancer Research and Treatment · 1999 · 38 citations · Full text

Medicine, Oncology, Pharmacology +14

The neu-oncogene product in serum and tissue of patients with breast carcinoma

R. Kath, K. Höftken, K. Metz et al. · Annals of Oncology · 1993 · 32 citations · Full text

Medicine, Oncology, Pathology +13

A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors

Heike Richly, P. Kupsch, K. J. Passage et al. · International Journal of Clinical Pharmacology and Therapeutics · 2003 · 29 citations

Medicine, Pharmacokinetics, Pharmacology +16